[Table/Fig-2]:
Baseline demographic and clinical characteristics
| Darifenacin (n = 30) | Trospium (n = 30) | ||
|---|---|---|---|
| Age (years) | Mean ± SD | 63.27 ± 9.15 | 64.87 ± 7.97 |
| Gender (Male) | n (%) | 22 (73.30) | 24 (80.00) |
| Fluid intake / day (ml) | Mean ± SD | 2133.33 ± 706.29 | 2466.67 ± 973.20 |
| Defecations / day | Mean ± SD | 1.07 ± 0.25 | 1.00 ± 0.00 |
| Systolic BP (mm Hg) | Mean ± SD | 146.67 ± 17.06 | 131.47 ± 18.83 |
| Diastolic BP (mm Hg) | Mean ± SD | 90.13 ± 11.49 | 83.33 ± 8.81 |
| Weight (kg) | Mean ± SD | 62.97 ± 18.35 | 70.07 ± 12.66 |
| BMI (kg / m2) | Mean ± SD | 24.21 ± 6.14 | 24.63 ± 4.25 |
| Waist circumference (cm) | Mean ± SD | 91.07 ± 16.34 | 95.53 ± 9.63 |
| OABSS | Mean ± SD | 9.87 ± 3.75 | 9.27 ± 3.21 |
| McMillan and Williams CAS | Mean ± SD | 0.27 ± 0.58 | 0.53 ± 1.17 |
| KESS questionnaire score | Mean ± SD | 3.73 ± 3.45 | 3.33 ± 4.41 |
| Bristol stool consistency | Mean ± SD | 2.6 ± 0.97 | 3.07 ± 0.87 |